Published in Toxicol Appl Pharmacol on February 01, 1991
Evidence that mouse brain neuropathy target esterase is a lysophospholipase. Proc Natl Acad Sci U S A (2003) 1.14
Further studies toward a mouse model for biochemical assessment of neuropathic potential of organophosphorus compounds. J Appl Toxicol (2014) 0.77
Organophosphate neurotoxicity to the voluntary motor system on the trail of environment-caused amyotrophic lateral sclerosis: the known, the misknown, and the unknown. Arch Toxicol (2017) 0.75
Rigour and qualitative research. BMJ (1995) 22.49
Qualitative research in health care. Assessing quality in qualitative research. BMJ (2000) 16.24
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Qualitative research: Observational methods in health care settings. BMJ (1995) 5.73
Impact of surgery for stress incontinence on morbidity: cohort study. BMJ (1997) 3.70
Waiting times for outpatient appointments. BMJ (1993) 2.97
Cellular mechanisms for developmental toxicity of chlorpyrifos: targeting the adenylyl cyclase signaling cascade. Toxicol Appl Pharmacol (1997) 2.42
Impact of surgery for stress incontinence on the social lives of women. Br J Obstet Gynaecol (1998) 2.28
Locomotion in larval zebrafish: Influence of time of day, lighting and ethanol. Neurotoxicology (2008) 2.12
Common mechanism of toxicity: a case study of organophosphorus pesticides. Toxicol Sci (1998) 2.08
Evaluating meta-ethnography: systematic analysis and synthesis of qualitative research. Health Technol Assess (2011) 1.87
Zymosan-induced arthritis: a model of chronic proliferative arthritis following activation of the alternative pathway of complement. Arthritis Rheum (1977) 1.82
Epidemiological and clinical characteristics of occult bacteremia in an adult emergency department in Spain: influence of blood culture results on changes in initial diagnosis and empiric antibiotic treatment. Eur J Clin Microbiol Infect Dis (2004) 1.50
Positive predictive value of the UK clinical case definition for H1N1/09 ('swine') influenza. J Infect (2010) 1.50
Adverse events in anaesthetic practice: qualitative study of definition, discussion and reporting. Br J Anaesth (2006) 1.47
Usefulness of flow volume loops in emergency center and ICU settings. Chest (1997) 1.43
Prospective assessment of two-stage testing for Clostridium difficile. J Hosp Infect (2010) 1.40
The aesthetic alliance: nurses and medical facials. Dermatol Nurs (1990) 1.39
Detraining: loss of training-induced physiological and performance adaptations. Part I: short term insufficient training stimulus. Sports Med (2000) 1.39
Making monitoring 'work': human-machine interaction and patient safety in anaesthesia. Anaesthesia (2003) 1.38
Intestinal barrier dysfunction in clinical and experimental obstructive jaundice and its reversal by internal biliary drainage. Br J Surg (1996) 1.23
Acute neuroactive drug exposures alter locomotor activity in larval zebrafish. Neurotoxicol Teratol (2009) 1.18
A bibliometric analysis of tuberculosis research indexed in PubMed, 1997-2006. Int J Tuberc Lung Dis (2008) 1.17
Carboxylesterase and A-esterase activities during maturation and aging: relationship to the toxicity of chlorpyrifos and parathion in rats. Toxicol Sci (2000) 1.13
Mental health status as a predictor of morbidity and mortality: a 15-year follow-up of members of a health maintenance organization. Am J Public Health (1994) 1.09
Cardiorespiratory and metabolic characteristics of detraining in humans. Med Sci Sports Exerc (2001) 1.09
Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine. Cancer Gene Ther (2006) 1.08
Expertise in practice: an ethnographic study exploring acquisition and use of knowledge in anaesthesia. Br J Anaesth (2003) 1.07
Changes in gastrointestinal morphology associated with obstructive jaundice. J Pathol (2000) 1.07
Detraining: loss of training-induced physiological and performance adaptations. Part II: Long term insufficient training stimulus. Sports Med (2000) 1.06
Muscular characteristics of detraining in humans. Med Sci Sports Exerc (2001) 1.06
Age- and gender-related differences in sensitivity to chlorpyrifos in the rat reflect developmental profiles of esterase activities. Toxicol Sci (1998) 1.05
Methods to identify and characterize developmental neurotoxicity for human health risk assessment. III: pharmacokinetic and pharmacodynamic considerations. Environ Health Perspect (2001) 1.05
Age- and gender-related differences in the time course of behavioral and biochemical effects produced by oral chlorpyrifos in rats. Toxicol Appl Pharmacol (1998) 1.05
Creatine supplementation and sprint performance in soccer players. Med Sci Sports Exerc (2000) 1.03
Cultural conflicts in the weight loss experience of overweight Latinos. Int J Obes (Lond) (2006) 1.01
Interprofessional handover and patient safety in anaesthesia: observational study of handovers in the recovery room. Br J Anaesth (2008) 1.01
Altered neurometabolite development in HIV-infected children: correlation with neuropsychological tests. Neurology (2004) 1.00
Tissue-specific effects of chlorpyrifos on carboxylesterase and cholinesterase activity in adult rats: an in vitro and in vivo comparison. Fundam Appl Toxicol (1997) 1.00
Gestational exposure to chlorpyrifos: apparent protection of the fetus? Toxicol Appl Pharmacol (1998) 1.00
Subjective health assessments and the perceived outcome of minor surgery. J Psychosom Res (1984) 0.99
Calcium and phosphorus solubility in neonatal intravenous feeding solutions. Arch Dis Child (1990) 0.98
A modified spectrophotometric method appropriate for measuring cholinesterase activity in tissue from carbaryl-treated animals. Fundam Appl Toxicol (1993) 0.98
IFN-gamma and IL-10 islet-antigen-specific T cell responses in autoantibody-negative first-degree relatives of patients with type 1 diabetes. Diabetologia (2010) 0.96
Epidemiology of community-acquired pneumonia in adult patients at the dawn of the 21st century: a prospective study on the Mediterranean coast of Spain. Clin Microbiol Infect (2005) 0.96
Physiological and performance characteristics of male professional road cyclists. Sports Med (2001) 0.96
Effect of inherited deficiency of the fifth component of complement on arthritis induced in mice by Mycoplasma pulmonis. Arthritis Rheum (1978) 0.96
Community-acquired pneumonia of mixed etiology: prevalence, clinical characteristics, and outcome. Eur J Clin Microbiol Infect Dis (2005) 0.96
Health status, utilization, and satisfaction among enrollees in three types of private health insurance plans. Group Health J (1982) 0.95
An invertebrate model of the developmental neurotoxicity of insecticides: effects of chlorpyrifos and dieldrin in sea urchin embryos and larvae. Environ Health Perspect (2001) 0.95
Acute administration of dopaminergic drugs has differential effects on locomotion in larval zebrafish. Pharmacol Biochem Behav (2012) 0.95
Maturational differences in chlorpyrifos-oxonase activity may contribute to age-related sensitivity to chlorpyrifos. J Biochem Toxicol (1996) 0.93
Inhibition of forskolin-stimulated cAMP formation in vitro by paraoxon and chlorpyrifos oxon in cortical slices from neonatal, juvenile, and adult rats. J Biochem Mol Toxicol (2001) 0.93
Rat brain acetylcholinesterase activity: developmental profile and maturational sensitivity to carbamate and organophosphorus inhibitors. Toxicology (1998) 0.93
Role of viable mycoplasmas in the pathogenesis of arthritis induced by M. pulmonis. Br J Exp Pathol (1981) 0.92
Effect of T-cell deficiency on the chronicity of arthritis induced in mice by Mycoplasma pulmonis. Infect Immun (1980) 0.92
Behavioral and neurochemical effects of acute chlorpyrifos in rats: tolerance to prolonged inhibition of cholinesterase. J Pharmacol Exp Ther (1993) 0.91
Comparison of the in vitro sensitivity of rat acetylcholinesterase to chlorpyrifos-oxon: what do tissue IC50 values represent? Toxicol Appl Pharmacol (1998) 0.90
Bacterial translocation and gut microflora in obstructive jaundice. J Anat (1996) 0.89
Swimming performance changes during the final 3 weeks of training leading to the Sydney 2000 Olympic Games. Int J Sports Med (2002) 0.89
Influence of body mass and height on the energy cost of running in highly trained middle- and long-distance runners. Int J Sports Med (2002) 0.89
Hormonal responses to training and its tapering off in competitive swimmers: relationships with performance. Eur J Appl Physiol Occup Physiol (1996) 0.89
Genetic evidence for coenzyme Q requirement in plasma membrane electron transport. J Bioenerg Biomembr (1998) 0.88
Development of a symptom severity index and a symptom impact index for stress incontinence in women. Neurourol Urodyn (1996) 0.88
Creatine supplementation as an ergogenic aid for sports performance in highly trained athletes: a critical review. Int J Sports Med (1997) 0.88
What defines expertise in regional anaesthesia? An observational analysis of practice. Br J Anaesth (2006) 0.87
Gestational exposure to chlorpyrifos: comparative distribution of trichloropyridinol in the fetus and dam. Toxicol Appl Pharmacol (1999) 0.87
Physiological variables to use in the gender comparison in highly trained runners. J Sports Med Phys Fitness (2004) 0.87
Modulation of neurotoxic esterase activity in vitro by phospholipids. Toxicol Appl Pharmacol (1989) 0.86
Neurobehavioral effects of chronic dietary and repeated high-level spike exposure to chlorpyrifos in rats. Toxicol Sci (2005) 0.86
Slow accumulation of acetylcholinesterase in rat brain during enzyme inhibition by repeated dosing with chlorpyrifos. Biochem Pharmacol (1995) 0.85
Risk of clinically significant depression in HIV-infected patients: effect of antiretroviral drugs. HIV Med (2013) 0.84
The effect of mode of agitation and type of plastic bag on storage characteristics and in vivo kinetics of platelet concentrates. Transfusion (1986) 0.84
An effective continuous quality improvement approach to the prevention of ventilator-associated pneumonia. Am J Infect Control (1993) 0.83
Improved efficiency for primer extension by using a long, highly-labeled primer generated from immobilized single-stranded DNA templates. Nucleic Acids Res (1997) 0.83
Symptomatic and physiologic outcomes after operative treatment for extraesophageal reflux. Surg Endosc (2002) 0.82
Fenthion produces a persistent decrease in muscarinic receptor function in the adult rat retina. Toxicol Appl Pharmacol (1994) 0.82
Extended storage of platelets in a new plastic container. II. In vivo response to infusion of platelets stored for 5 days. Transfusion (1985) 0.82
The impact of dose rate on the neurotoxicity of acrylamide: the interaction of administered dose, target tissue concentrations, tissue damage, and functional effects. Toxicol Appl Pharmacol (1996) 0.82
SLE in a United States-Mexico border community. J Clin Rheumatol (2001) 0.82
The dynamics of successive induction in larval zebrafish. J Exp Anal Behav (2010) 0.81
Venous clots: evaluation with MR imaging. Radiology (1987) 0.81
Gestational exposure to chlorpyrifos: dose response profiles for cholinesterase and carboxylesterase activity. Toxicol Sci (1999) 0.81
Clinical characterisation of pneumonia caused by atypical pathogens combining classic and novel predictors. Clin Microbiol Infect (2007) 0.80
Pullorum disease in Delaware roasters. Avian Dis (1993) 0.80
A bibliometric overview of infectious diseases research in European countries (2002-2007). Eur J Clin Microbiol Infect Dis (2009) 0.80
Rearing conditions differentially affect the locomotor behavior of larval zebrafish, but not their response to valproate-induced developmental neurotoxicity. Neurotoxicol Teratol (2011) 0.80
The neurotoxicity of subchronic acetylcholinesterase (AChE) inhibition in rat hippocampus. Toxicol Appl Pharmacol (1990) 0.80
Bioactive glasses as accelerators of apatite bioactivity. J Biomed Mater Res A (2003) 0.80
Quantitative, video-based histochemistry to measure regional effects of anticholinesterase pesticides in rat brain. Anal Biochem (1996) 0.79
High rates of susceptibility to ceftazidime among globally prevalent CTX-M-producing Escherichia coli: potential clinical implications of the revised CLSI interpretive criteria. Eur J Clin Microbiol Infect Dis (2011) 0.79
The relationship of oral chlorpyrifos effects on behavior, cholinesterase inhibition, and muscarinic receptor density in rat. Pharmacol Biochem Behav (1997) 0.79
A Mono-Percoll separation technique improves sperm recovery of normal and male factor specimens when compared with the swim-up technique. Hum Reprod (1995) 0.79
Physiological and performance responses to a 6-day taper in middle-distance runners: influence of training frequency. Int J Sports Med (2002) 0.79
The neurotoxicity of parathion-induced acetylcholinesterase inhibition in neonatal rats. Neurotoxicology (1990) 0.79
Nephrotic syndrome and AA amyloidosis revealing adult-onset cryopyrin-associated periodic syndrome. Ren Fail (2013) 0.79
Chromatographic removal combined with heat, acid and chaotropic inactivation of four model viruses. J Biotechnol (2002) 0.79
The neurotoxicity of parathion-induced acetylcholinesterase inhibition in neonatal rats. Neurotoxicology (1990) 0.79
An S1 nuclease mapping method for detection of low abundance transcripts. Anal Biochem (1996) 0.78